<SUBMISSION>
<ACCESSION-NUMBER>0001193125-08-253653
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20081212
<ITEMS>8.01
<FILING-DATE>20081215
<DATE-OF-FILING-DATE-CHANGE>20081215
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DAVITA INC
<CIK>0000927066
<ASSIGNED-SIC>8090
<IRS-NUMBER>510354549
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-14106
<FILM-NUMBER>081250517
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
<PHONE>3105362400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE HOLDINGS INC
<DATE-CHANGED>19950524
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE INC
<DATE-CHANGED>19940719
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P
STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P
STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>Form 8-K </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Pursuant to
Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (date of earliest event reported): December&nbsp;12, 2008 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P
STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>DAVITA INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>1-14106</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>No. 51-0354549</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(State or other</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>jurisdiction of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>601 Hawaii Street </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>El Segundo, California 90245 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices
including Zip Code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(310) 536-2400 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not applicable </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P
STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P
STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Other Events. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Attached hereto as Exhibit 99.1 is a
press release issued by DaVita Inc. on December&nbsp;15, 2008. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Exhibits. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated December&nbsp;15, 2008.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Date: December&nbsp;15, 2008 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">D<SMALL>A</SMALL>V<SMALL>ITA</SMALL> I<SMALL>NC</SMALL>.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ Joseph Schohl&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Joseph Schohl</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2">Vice President, General Counsel and Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated December&nbsp;15, 2008.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g19347g97z62.jpg" ALT="LOGO"> </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Contact:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">LeAnne&nbsp;Zumwalt</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">(650) 696-8910</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Previously Reported Investigation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">EL SEGUNDO, Calif.,
December&nbsp;15, 2008, DaVita Inc. (NYSE: DVA), today announced that it is working with the U.S. Department of Health and Human Services, Office of Inspector General (&#147;OIG&#148;) to respond to a subpoena request for documents issued in
connection with the civil investigation by the Department of Justice and the U.S. Attorney&#146;s Office for the Northern District of Georgia previously reported in the Company&#146;s Quarterly Report on 10-Q for the period ended September&nbsp;30,
2008. The subpoena was sent from the OIG&#146;s office in Atlanta, Georgia and was received by the Company on December&nbsp;12, 2008. The subpoena applies to the Company and its subsidiaries and covers a time period from January&nbsp;1, 2003 to the
present. In response to the subpoena, DaVita will produce a wide range of documents relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlicit, and Epogen. The Company intends to meet with representatives of the government to
discuss the scope of the subpoena and the production of responsive documents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">To the Company&#146;s knowledge, no proceedings have been initiated against
the Company at this time, although the Company cannot predict whether or when proceedings might be initiated. The Company intends to cooperate with the government&#146;s investigation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">&#147;DaVita has been involved in&nbsp;several investigations over the last 9 years, including some covering issues that are repeated in this subpoena.&nbsp;We respect the government&#146;s need to ensure the
appropriateness of healthcare provider practices, especially during times when pharmaceutical issues involve significant expense for Medicare.&nbsp;We look forward to meeting with government representatives on this new investigation and once again
demonstrating the strength of our clinical outcomes and the integrity and comprehensiveness of DaVita&#146;s Compliance programs,&#148; said LeAnne Zumwalt, spokesperson for DaVita. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2"><I>DaVita is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400
outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. </I></FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g19347g97z62.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g19347g97z62.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!:`1X#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BDZ#-8-S+>^(6:VT^9[/3@VV:]3B2;U6+T';?\`EZTTKB;L,UGQ
M?!8WATS3+675M4[VUOTC]W;HHK*;0/&FODOJ^O+I,#$_Z+IP^8#T+_\`ZZZK
M2](L-&M!;:?;)!'G+8Y+GU8]2?<U=J^=1^%$\K?Q'$Q_"?P[G?=27UY(1\SS
M7!R?R`IMQ\)/#<@S;M>6L@^Z\<^<'UY!KN**?MJG<7LX=CS"[T#QSX/7[3HN
MKRZM9Q\FWE!9@/\`=).?^`D'VK9\)?$O3]?=+*_5;#4"=H4G]W(?12>A]C^M
M=M7GGQ%\`IJ<$FM:3%LOHANEB08$RCN!_>'ZUI&<:GNSW[D2C*&L?N/0Z*\[
M^&OCMM61=$U27-[&O[B5O^6RCL?]H?J*]$K&<'"5F:PDI*Z"BBBH*"BBB@`H
MHHH`***S;'5$EMII+B15\ERI;L1VK*=6$)*,G:]_P+C"4DVNAI450TNZ>]6>
MX.1&TF(P>P`J_3I5%5@IQV83@X2Y6%%%%:$!1110`4444`%%%%`!1110`4R1
M7:)EC?8Y!"MC.T^N.]/HH`XSQ-+X@\.Z!<ZHWB02F$#9&;&,;V)``Z^]<+I?
MQ%\8:IJMK817D`>YE6,'[,O&3U_"N@^,VJ;+&PTE&^:5S/(/9>!^I/Y5SOPE
MTO[;XM-XRY2QA+\_WF^4?U_*N^G&*I.<D<<V_:*,6>H_V3XB_P"AH_\`)"/_
M`!JO/IOC.`F2T\06-SCI%<V6P'ZLIS7345Q\[\ON1U<J.%@\<QO?G0/%MBVE
M7+$#<'S!,/\`>[*?R]37<(JJBJ@`4#"A>@'M7"?%S28[OPLNH;!YUE*OS=]C
M':1^>/RJ#X3^*9=2L9=%O92\]FH:%F/+1=,?\!/Z$>E:R@I4^>/S,U-J?)(]
M$HHHKG-@HHHH`****`/$OB+H,OA?Q1#J^G$PQ73^=$4'^JE!R1_7\37JGA37
MX_$GA^WU%<+(PV3(/X9!U']1[$56\=:&->\*7=NJ@SQ+YT)Q_$O./Q&1^-><
M_"/7OL.NR:3,^(;]<H#VD4?U&?R%=C_>T;]4<W\.I;HSVBBBBN,Z0HHHH`*:
MZ[T*[BN>X/(IU%#U`P]4&K6T#NMVK0CJ0H5A_GVKG5*[@')VYYQUKI=2$VJ7
M(L+?B.,YFD[`^E7K?3;2WMQ"(4<#J74$FOG*^!GBJ[Y)/E75MO7K;R/6IXF-
M&FN9:OMIIYAILEK)9)]D_P!4O&#U!]_>K=5(-/BM;DRV_P"[1QAXQT)[$>E6
MZ]V@IJ"C-)-=MOD>;4Y7*\6%%4-4UO2]%1'U.^AM1)G9YC8W8ZX]:H:+XPTS
MQ#J4]II1DN$MTW27&PJ@).`!GDD\]NU="C)J]M#+F5[&]1114C"BBB@`HHHH
M`****`"BBJFJWZ:7I-W?R8VV\+2<]\#I0E?0-CPOXC:I_:GC6]*MF.V(MT_X
M#U_\>)KT'X0:7]D\,S7[+A[V8D'_`&%X'Z[J\:8S7ET6.7FG?/\`O,Q_Q-?2
MFB::ND:)9Z>G2WA5"?4XY/YYKT,2^2FH(XJ'O3<B_1117GG:<A\49UA\"7BM
MUE>-%^N\'^E>7?#B[:T\=:>03B8M$P'<%3_7%=I\9]0V:?IVFJW,LK3./91@
M?JQ_*N*^'5JUUXZTT`'$;M(<=@%/_P!:O1HJU!W\SBJ.]96\CZ!HHKBO&'Q(
ML/#CO96:K>ZBO#)GY(C_`+1]?8?I7!&$INT3KE)15V=K2!E)P"/SKS;PYHVO
M^-81JWB35;J&PE.8;*W8Q"1?4XZ+Z=S72-\//"YCQ%IQ@<?=FAF=74^H.>M7
M*$8NS9*E*2ND=-17EWB;Q/K?@_3[K09;V6:Z8H]A?L`7:$GY@W;<,8SWS2?#
M+6O$?B#7)WO]4FFL[6++HRKAF;A1P/J?PJO8/D<[Z$^U7-RVU/4:^>?$-O+X
M6\<W/V<;&M;H3P?[I.Y?T.*^AZ\<^,EAY.O65^HP+F`HQ]U/^#"KPLK3Y>Y.
M(7NW['K=C=QW]A;WD)S'/&LB_0C-6*XOX5:E]N\&QV[-E[*1H2/0?>7]#^E=
MI6$X\LFC:,N:*84445!055COHI[Z6TB#.81^]D7[J,>BY]<<X[?C6%JVNW&H
M:J?#N@2`W6,WEX.5LT_JY[#MWK9@TJ*RT@Z=82/;#856489PQZN2>K9YR>]6
MXV6I-[O0MQQI$@2-0JCL*=7D_C[4-9\*M:VMMXIU"XGN`SNKA%VJ.`<A0>3G
M\JD^%45_K6L7>MZG>7%U]E7RHC-(6P[=2,^@_G6GL+4^:^AG[:\^6VIZK117
M)>);&^T^RU#6#XHU""&)6D6"-(]J^BC*YZX%91CS.QK)V5SS?XI:Q_:GBZ2W
M1]T-@HA7TW=6_7C\*]!^%FC'3/"27,BXEOW\X^NWHH_+G\:\;TNRGU_7;>S+
MLTU[.`[GD\G+-_,U[A#X1U*"%(8?%NII'&H5%$<6%`&`/NUW5[1@J=SDHWE-
MSL=115'2;"XTZV:*YU*XU!R^[S9PH('I\H`Q5+Q/XLTWPK9":]<M,X/DVZ??
MD/\`0>YKA46W9:G6VDKLVZ0LH."0/QKRG2M4\6?$?49!%>/I&DPG$K6W!_W=
MW5F_(#TKL(OAWX72(++IYN7Q\TT\SL['U)S6DJ:AI)ZD1FY:Q1T]%<+J,D_P
MZ874,\]UH<P*&WF<NUM+@E=I/.TD8(/3-<+H/BSQ?KGB"ST]-9G'VB8!]JK\
MJ]6[=AFJC0<DY)Z$RJJ+LUJ>Z44@Z4M<YL%<-\6M4^Q>$Q9JV'OI@F/]D?,?
MY#\Z[FO%?B]JGVOQ/#8*V4LH1D?[;<G]-M;X>/-41C6E:#,?X>Z7_:OC2QC9
M<QP,9W^B\C]<5]!5Y;\&-+Q'J.K.OWB+>,^P^9O_`&6O4JK%2O4MV%AXVA?N
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M?XD_E2C:E0YENP?[RK9[(]&1%C1410JJ,``8`%.HK.U_58]$T*\U*3&+>(LH
M/=NBC\3BN!)MV.QNRN>-?%+5UU/QA)#&08[%!!GU;JWZG'X5Z+\,-&_LKPA#
M-(FV:^8SOGKM/"C\N?QKQK2;&?Q#XAMK-F+2WL_[Q^IY.6/Y9-?2<,4=O#'#
M$H6.-0JJ.P`P!7;B'R05-'+0]Z3FQ]>>_&.T\WPW:70',%T`?HRD?S`KT*N5
M^)5O]H\":A@$F,)(,'T89_3-<U%VJ(WJJ\&<9\&;\QZIJ.G$\31+,H]U.#_Z
M$/RKUVOG_P"'-Y]B\<Z><X68M"??<IQ^N*^@*UQ4;5+]S/#N\+!7">*?&-U=
M:DOACPJPEU*5BDUP.5MQWP?4=SV^M9WCKQ_,]P?#WAMGDNY'$<D\7)!/\">_
MJ>U=%X%\&Q>%M-,D^)-1N0#/)UV_[`/H/U-2H*$>>?R13DYOEC\S3\,^';7P
MUI*65O\`/(QWSS'[TKGJQK7HK"\::R-"\*7UX&VRF/RX?7>W`_+K^%8ZSEYL
MTTC$\5\<ZQ_;?BZ^NE;,4;^3%C^ZO&?Q.3^->R^!-&&A^$;*W9=LTJ^=-Z[F
MYQ^`P/PKQ;P9H_\`;GBNQLW4M$'\R;_<7D_GP/QKZ*Z5V8IJ*5-'-AU=N;%K
MS?XQ:S]GTJTTB-\-=/YDH']Q>GYG^5>D5\]>/=9&M^+KVX1LPPMY$7^ZO!/X
MG)K+#0YIW[&E>5H6[G2?!W1_M&KW6KR)E+5/+B)_OMU_(?SKV&N<\!:-_8GA
M"R@=-LTR^?-Z[FY_08'X5T=17GSS;*I1Y8)&?KNL6^@Z-<ZE<GY(4R%[NW91
M]37SU?7VH^*-=\Z=C-=W<@1%[+DX"CT`KT[XSW,B:)I]LIPDMP6;WVKQ_.N4
M^%.EK?\`C!;B10R6,32\_P!X_*O\R?PKIH)0INH85FYS4#V#0-&M]`T6VTVW
M`VPI\S=W;^)C]36E12=!DUPMMN[.M*RLCS7XR:P(M/L]&0_/._GR>RKP/S.?
MRK.^#>C^;?7FLR+Q`OD1?[QY8_EC\ZY'QKK/]N>*[Z\5]\*OY4)']Q>!CZ\G
M\:]K\$:-_8?A.RM'3;,R>;-_OMR?RX'X5W3_`'5!1ZLY(?O*KEV-^BBBN`[!
MKNL:,[G"J,DGL*^:-<U%M6UR]U!C_P`?$S./9<\#\L5[S+X12>)XI=<UIXW4
MJRF\X(/4=*QO^%1>%_\`I]_[_P#_`-:NNA4A3NV<]6$YV2-CP)I?]D>#M/MV
M7;(\?G2?[S?-_(@?A70U@#PH%``U[6@!P`+OI^E#>%`RE3K^MX/!Q>X_I6$K
M2;;9JKI6L7M:U[3?#]BUWJ-RL2`?*N<LY]%'<UXQJ5QKOQ,\0[[*T?R8_DB4
M_P"K@7U9NF3WKTZ/X<>'3=&YO(KG49O[]Y<-)_6NDMK6WLH%@M8(X(EZ)&@5
M1^`K2%2%/6.K(E"4]'HC`\'>"[/PG9G:1/>S`>=<$=?]E?1?YUTM%%8RDY.[
M-4E%61Y)\8=!E2]M]>A0F&1!#.1_"P^Z3]0<?A76?"V2)_`EHL;`E'D5QZ-N
M)_D1757%O#=V\EO<1)+#(NUT<9##T(KE8?A^FE7<EQX=UJ\TD2G+PJ%EC/\`
MP%JV]HI4^270RY'&?,CKB0!DG`%>3_$S7KC7-/>/2U,FD64ZK<70/RRRG.%7
MU"]R.Y%=H?"5S>_)K?B&^U&#O;J%@C<>C!`"?SK5O-"TV^T5]'EM46R9-@BC
M&T*.HQCH0>:F$HTY)[CFI35MCR_X.:4L^KWFJN`1:QB./V9NI_(?K7>ZAXCF
MEUZ#0M#6.XNE</>RMDI;1`\@X_B/0"L73_A>^DRRG3O$^HVL4W$B1!5+#MSZ
M^^*ZS1="T_0+,VNGP[%9MTCL=SR-ZLQY)JZLX2DY;DTXRC'EV-&L;QA#]H\'
MZM'LWYM7(7W`S_2MFJ.MHTN@ZA&@RS6L@`]3M-81TDC:6S/G#2KHV6K6=VI`
M,$Z29/LP->C?$#XC^:)-&T&8%&&V>[C/7U5#_,_E7EXZ"O2_ACX&^U/'X@U2
M+]PAW6D3#[Y'\9'H.WYUZE905IRZ'GTG)^['J;7PU\##2+==9U.+_3IE_<QL
M/]0I_P#9C^@_&O0J**\R<W.5V=\(J*L@KR[XTWDJPZ79#B)V>5O=@`!_Z$:]
M1K)\0^&M-\3V(M-2B9@C;HW0[70^H-52DH34F34BY1:1P_P:TE%L[[6'`+R/
M]GC]E&"WYDC\JZG6=?NKB]&B>'&CFU$D>?.1NCLUSR6[%O1>M9FF_"ZPT[S$
M36M5^SR'+P1S^6K_`.]M'-=;INE6.CV@M-/M8[>$'.U!U/J3U)]S5U)Q<W+<
MF$9*/+L0ZY<S6/AV_N8OFFAM7=2!C+!3S7@/A+3!K7BK3[*3+)),&D[Y5?F/
M\J^C6574HZAE88((R"*XF?X5Z.NI+?Z9>WNF2J^]1`X(0_[.1D?G54*L8)I]
M15:;DTT=E=7=M86KW-U-'!!$,L[G`45S:-=^,KB.5?.L]!B<.O)26^(Z'U6/
M//J?I5J#P?9&XCN=4NKO5YHSE#>R;D0^H0`+^E;]874=MS2S>YR'Q-T";7/#
M!>UC,ES9/YRH.K+C#`?AS^%<K\%I81>ZK&642M'&54]2H+9Q^8KUJN5U'X?Z
M9<:G_:NFW%QI%_DDRVA`#$]<J>.?UK6%5>S=.1$J;YU-'55R'C77KC[+/H6A
MCS]3EA9IBAP+:(#)9CV)'`'O5L>&];E^2[\7WSPG[RP6\4+'_@0&1^%:NE:)
MIVC6S06-LL:N<R,?F>4^K,>6/UK-<L7?<MWDK;'@7@O25UOQ7I]DZ[HC)YD@
M]47YB/QQC\:]R\2>(X=!MXXXT^TZC='9:6B_>E;^BCN:YV;X5VD6L'4M'U>[
MTM]Q95B4-L)ZA3Z>U;^A^%+/1[E[Z2>>_P!1E&U[RZ;<^/0?W1["MZU2$VI7
M^1C2A*":+$VI7&DZ%#<:FHGO"$C,=LN/,E8X"KD^I[U@V_Q)L4#2:G:M:6_`
M6=&\U=W/R'`!#<$^G!KI]5TR'5K%K69WC^9722,X:-U.58'U!%<Y!\.]/:(0
M:G<O>VZ@%8%41(7'_+1MO+/CC.>G:LH>SM[QK+GO[IU]%%%8F@4444`%%%%`
M!1110`4444`%%%%`!1110`56U'_D&W7_`%Q?^1JS5;4/^0;=?]<7_D::W$]C
MQ?X>>!F\17*ZCJ$9&F0MT/'GL/X1[>I_"O;T18T5$4*JC"J!@`>E5=)AB@TB
MSBAC2.-84VHB@`<#L*N5K6J.<M3.E!0CH%%%%8FH4444`%%%%`!1110`4444
3`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
